Gemma English, DPM
Foot Surgery · Braselton, GANPI 1144668666
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 113 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Smith+Nephew accounts for 76.7% of it on its own, with 28 other manufacturers making up the rest.
Across 113 payments — averaging $31.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$3K
- Nevro Corp.$158
- Aroa Biosurgery Incorporated$63
- Organogenesis Inc.$57
- Treace Medical Concepts, Inc.$49
- Polynovo North America LLC$37
- plus $464 from 23 others
What the payments were for
- Food & beverage$3,53899%
- Education$191%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 76 | $2,730 |
| Nevro Corp. | 4 | $158 |
| Aroa Biosurgery Incorporated | 3 | $63 |
| Organogenesis Inc. | 2 | $57 |
| Treace Medical Concepts, Inc. | 3 | $49 |
| Polynovo North America LLC | 1 | $37 |
| Stimwave Technologies Incorporated | 2 | $33 |
| Vertex | 1 | $29 |
| Alnylam Pharmaceuticals Inc. | 1 | $28 |
| Cagent Vascular Inc | 1 | $27 |
| Averitas Pharma Inc. | 1 | $26 |
| Abbott | 1 | $25 |
| Globus Medical | 1 | $24 |
| Acera Surgical, Inc. | 1 | $23 |
| Convatec Inc. | 1 | $22 |
| Paratek Pharmaceuticals, Inc. | 1 | $22 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $20 |
| Stryker | 1 | $20 |
| ERMI LLC | 1 | $19 |
| Reprise Biomedical, Inc. | 1 | $19 |
| Trice Medical, Inc. | 1 | $18 |
| Integra Lifesciences Corporation | 1 | $17 |
| Access Pro Medical, LLC | 1 | $16 |
| Solventum Corporation | 1 | $15 |
| Zyla Life Sciences, Inc. | 1 | $13 |
| Osiris Therapeutics Inc. | 1 | $13 |
| Zimmer Biomet | 1 | $13 |
| Johnson & Johnson | 1 | $12 |
| Pacira Pharmaceuticals Incorporated | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Stravix$1,011
- GRAFIX PL$781
- Grafix$473
- STRAVIX PL$243
- Oasis$143
How this compares
Too few foot surgery providers in Georgiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 38 | $178 |
| Cephalexin | 16 | $90 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Braselton
- Edward SzaboAugusta$4K
- Marieli ColonForest Park$3K
- Ifeoma NwaedozieRome$3K
- Charles KeanAugusta$1K
- Anastasia ThomasStone Mountain$470
- Anthony GordonAthens$362
- Felicia PierreTucker$318
- Jessica BrownAtlanta$256
- Ebony ConnerPeachtree City$218
- Michael CantrellConyers$129
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.